Revolutionary Drug Mimics High-Altitude Health Benefits In the quest for longevity and improved health, scientists are exploring unconventional avenues that mimic the physiological benefits of high-altitude living. Researchers from the Gladstone Institutes have made a groundbreaking advancement by developing a drug that replicates the cellular advantages of low-oxygen therapy, specifically targeting inherited mitochondrial diseases. This innovative approach could change the lives of many, particularly those battling deadly conditions like Leigh Syndrome.

READ THIS ARTICLE IN FULL ON BRAIN HEALTH ON-LINE: #HighAltitudeLiving #MitochondrialDiseases #LeighSyndrome #HypoxyStat #BiomedicalResearch #Longevity #HealthInnovation #DrugDevelopment #GeneticConditions #ClinicalTrials #OxygenTherapy #GladstoneInstitutes #MazeTherapeutics #CellularHealth #Brain

The colloquium series hosted by the Eric and Wendy Schmidt Center at the Broad Institute of MIT and Harvard and MIT EECS is restarting soon!

Register at: lnkd.in/eZH_h8CV

#SchmidtCenter @broadinstitute.org #MITEECS #BarbaraEngelhardt #GladstoneInstitutes #StanfordDBDS